Trial intelligence / Profile preview

Efficacy and Safety of Luliconazole in Tinea Pedis

NCT01396785Phase 3Completed

Sponsor
Medicis Pharmaceutical
Start
Jul 2011
Primary completion
Jan 2012
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of luliconazole in tinea pedis, sponsored by Medicis Pharmaceutical. Started Jul 2011; status: completed.

02

Drugs

luliconazole
03

Conditions

tinea pedis

Beyond the preview

Go deeper on NCT01396785.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01396785.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call